- Home
- BR vs WAT Comparison
BR vs WAT Comparison
Compare BR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BR
- WAT
- Stock Information
- Founded
- BR 1962
- WAT 1958
- Country
- BR United States
- WAT United States
- Employees
- BR N/A
- WAT N/A
- Industry
- BR Business Services
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- BR Consumer Discretionary
- WAT Industrials
- Exchange
- BR Nasdaq
- WAT Nasdaq
- Market Cap
- BR 27.6B
- WAT 22.5B
- IPO Year
- BR 2007
- WAT 1995
- Fundamental
- Price
- BR $234.26
- WAT $386.99
- Analyst Decision
- BR Buy
- WAT Hold
- Analyst Count
- BR 6
- WAT 13
- Target Price
- BR $217.83
- WAT $363.92
- AVG Volume (30 Days)
- BR 547.3K
- WAT 558.0K
- Earning Date
- BR 11-05-2024
- WAT 11-01-2024
- Dividend Yield
- BR 1.50%
- WAT N/A
- EPS Growth
- BR 2.64
- WAT N/A
- EPS
- BR 5.79
- WAT 10.48
- Revenue
- BR $6,498,600,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- BR $9.45
- WAT $0.53
- Revenue Next Year
- BR $5.42
- WAT $5.59
- P/E Ratio
- BR $40.48
- WAT $36.72
- Revenue Growth
- BR 4.67
- WAT N/A
- 52 Week Low
- BR $188.30
- WAT $279.24
- 52 Week High
- BR $237.74
- WAT $395.44
- Technical
- Relative Strength Index (RSI)
- BR 69.05
- WAT 61.43
- Support Level
- BR $222.01
- WAT $372.15
- Resistance Level
- BR $237.74
- WAT $395.44
- Average True Range (ATR)
- BR 3.20
- WAT 10.33
- MACD
- BR 0.73
- WAT 1.18
- Stochastic Oscillator
- BR 77.88
- WAT 84.59
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communications and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.